CRGC News Broadcast

NB-2026-002

April 2, 2026

Official SEER Announcement regarding PI-RADS and LI-RADS



On behalf of SEER, we would like to formally announce an update to our coding instructions regarding PI-RADS and LI-RADS. NCI SEER has decided to adopt the same instructions regarding PI-RADS and LI-RADS as the STORE manual (CoC) putting both standard setters back in alignment.

 

This is applicable as of NOW (your next prostate or liver case). Per the 2026 STORE Manual: PI-RADS and/or LI-RADS results alone are not reportable to CoC. PI-RADS and/or LI-RADS confirmed with biopsy or physician statement are reportable to CoC. The date of the biopsy or definitive statement from the physician is the Date of Diagnosis.

 

Please note:

  • There is no recommendation to review cases already abstracted for 2018+. You do not need to review any older cases. Start applying this rule to the next Prostate or Liver case you abstract.
  • Please note that any previous versions of the SEER Manual/appendices, including the 2026 SEER manual and the 2026 Appendix E will NOT be updated. This update will be included in the 2027 SEER manual and appendices.
  • Relevant SINQ questions will be updated within the next month.

 

Previously,

SEER changed their rules regarding PI-RADS and LI-RADS in 2018 to

  • When the only information was available was PI-RADS or LI-RADS report with a 4 or 5, that case was considered reportable
  • If a report had a PI-RADS or LI-RADS with a 4 or 5 with a subsequent biopsy, the date of diagnosis was the date of the PI-RADS or LI-RADs.
  • Note: These instructions only apply to PI-RADS and LI-RADS. SEER coding instructions regarding remaining RADS were always in alignment with the STORE manual.

 

Prior to 2021, SEER followed the same instructions as CoC.

 

The decision to change reportability for PI-RADS and LI-RADS was based on the terminology that was used in these reports; however, this decision caused great confusion amongst the SEER community. After NCI SEER discussed this both internally and with the SEER Central Registries, we have decided to remove this instruction.                                                                                                         

 

We hope this change will make abstracting prostate and liver cases slightly easier for you.

 

Please send any questions to Ask a SEER Registrar - SEER Registrarss and choose category SEER Manual.



 

If you have questions or concerns regarding any of the content of this CRGC News Broadcast please contact me.


Nankee Singh, ODS

Cancer Registry of Greater California